The global elastomer infusion pump market was valued at $534 million in 2018, and is estimated to reach at $745 million by 2026, registering a CAGR of 4.2% from 2019 to 2026. Elastomeric infusion pumps are non-electric, disposable pumps that deliver fluids such as antibiotics, analgesics, and chemotherapy drugs, in a patient’s body in controlled amount. The elastomeric infusion pump consist of elastomeric layer which provide required pressure for administrating the drug. These pumps provide advanced benefits over conventional infusion pump in features such as portability, feasibility, and less scope for human errors. In addition, these pumps do not require electricity and action of gravity. Moreover, it can be used for a variable period ranging from few minutes to several days. There are two types of elastomer infusion pumps that include continuous rate pumps, and variable rate pumps.
Rise in demand for small disposable elastomer infusion pump, due to its long term home care rehabilitation program, surge in prevalence of chronic diseases, growth in availability of elastomer infusion pumps, technological development of novel elastomeric infusion pumps are the key factors that fuel the growth of the elastomer infusion pump market. In addition, post-operative pain in surgeries such as total hip replacement and total knee replacement is usually treated by infusion of analgesics through elastomer infusion pumps. Therefore, significant increase in number of orthopedic procedures & surgeries is expected to drive the growth of the market. For instance, according to American Academy of Orthopedic Surgeons Annual report in 2018, approximately 1 million patients and over 1.4 million hip & knee arthroplasty procedures & surgeries were registered into the American Joint Replacement Registry. Moreover, elastomer infusion pumps have fewer adverse effects as compared to electronic pumps and are less costly, which fuels their adoption in ambulatory chemotherapy and analgesic infusion centers. Furthermore, elastomer infusion pumps are available in small size, light weight, disposable, and eliminate programming errors. Such advantages of elastomer infusion pumps over conventional electric infusion pump are expected to drive the growth of the market. However, low income and lack of proper medical attention in developing countries hamper the growth of the elastomer infusion pump market.
The global elastomer infusion pump market is segmented into product, application, and end user. By product, the market is categorized into continuous rate pumps, and variable rate pumps. The applications covered in the study include pain management, infection management, chemotherapy, and others. Based on end user, the market is bifurcated into hospitals and clinics, ambulatory care, and home care. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS
By Product
By Application
By End User
By Region
LIST OF KEY PLAYERS PROFILED IN THE REPORT
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Rise in demand for small disposable elastomer infusion pump, due to its long term home care rehabilitation program, surge in prevalence of chronic diseases, growth in availability of elastomer infusion pumps, technological development of novel elastomeric infusion pumps are the key factors that fuel the growth of the elastomer infusion pump market. In addition, post-operative pain in surgeries such as total hip replacement and total knee replacement is usually treated by infusion of analgesics through elastomer infusion pumps. Therefore, significant increase in number of orthopedic procedures & surgeries is expected to drive the growth of the market. For instance, according to American Academy of Orthopedic Surgeons Annual report in 2018, approximately 1 million patients and over 1.4 million hip & knee arthroplasty procedures & surgeries were registered into the American Joint Replacement Registry. Moreover, elastomer infusion pumps have fewer adverse effects as compared to electronic pumps and are less costly, which fuels their adoption in ambulatory chemotherapy and analgesic infusion centers. Furthermore, elastomer infusion pumps are available in small size, light weight, disposable, and eliminate programming errors. Such advantages of elastomer infusion pumps over conventional electric infusion pump are expected to drive the growth of the market. However, low income and lack of proper medical attention in developing countries hamper the growth of the elastomer infusion pump market.
The global elastomer infusion pump market is segmented into product, application, and end user. By product, the market is categorized into continuous rate pumps, and variable rate pumps. The applications covered in the study include pain management, infection management, chemotherapy, and others. Based on end user, the market is bifurcated into hospitals and clinics, ambulatory care, and home care. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
- A comprehensive analysis of all the regions is provided to determine the existing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
- Continuous Rate Pumps
- Variable Rate Pumps
By Application
- Pain Management
- Infection Management
- Chemotherapy
- Others
By End User
- Hospitals and Clinics
- Ambulatory Care
- Home Care
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- B Braun Melsungen Ag
- Baxter International Inc.
- Halyard Health
- Heka Healthcare
- Nipro Medical Corporation (Nipro Medical Europe NV)
- Palex Medical SA
- Pfizer Inc. (Hospira Inc.)
- Pfm Medical Ag
- Promecon GmbH
- Samtronic SA
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
- Avanos Medical
- Coopdech
- Woo Young Medical
Frequently Asked Questions about the Global Elastomer Infusion Pump Market
What is the estimated value of the Global Elastomer Infusion Pump Market?
What is the growth rate of the Global Elastomer Infusion Pump Market?
What is the forecasted size of the Global Elastomer Infusion Pump Market?
Who are the key companies in the Global Elastomer Infusion Pump Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 210 |
| Published | January 2020 |
| Forecast Period | 2018 - 2026 |
| Estimated Market Value ( USD | $ 534 million |
| Forecasted Market Value ( USD | $ 745 million |
| Compound Annual Growth Rate | 4.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Elastomer Infusion Pump Market, By Product
Chapter 5: Elastomer Infusion Pump Market, By Application
Chapter 6: Elastomer Infusion Pump Market, By End User
Chapter 7: Elastomer Infusion Pump Market, By Region
Chapter 8: Company Profiles
Executive Summary
According to the report, titled, 'Elastomer Infusion Pump Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026,' the global elastomer infusion pump market size was valued at $534 million in 2018, and is projected to reach $745 million by 2026, growing at a CAGR of 4.2% from 2019 to 2026.Elastomer infusion pumps are disposable medical devices that are used for administration of intravenous (IV) drugs such as antibiotics, analgesics, chemotherapy, and other medications. These devices use energy in an elastic membrane (inside the pump) to provide the force for drug delivery. In addition, it provides advantages over conventional electronic pumps in features such as portability, feasibility, and lesser scope for human errors. However, pump failure can have a significant impact on patient safety, making it required for pumps to be operated by a trained professional. The two major types of elastomer infusion pumps are continuous rate pumps, and variable rate pumps.
The major factors that boost the growth of the global elastomer infusion pump market are increase in demand for elastomer infusion pumps, rise in prevalence of chronic diseases, increase in number of surgeries, surge in preference for long-term home healthcare, technological development of novel elastomeric infusion pumps, rise in burden on hospitals to reduce healthcare costs, and rise in availability of elastomer infusion pumps. In addition, factors such as longer storage and stability of the drug, reduced cost, portability and reduce risk of introduction of an infection, are expected to further influence the growth of the elastomer infusion pumps market. However, low income and lack of proper medical attention in developing countries hamper the growth of the elastomer infusion pump market.
Based on product, the elastomer infusion pump market is categorized into continuous rate pumps, and variable rate pumps. Presently, continuous rate pumps dominates the global market, and is anticipated to continue this trend during the forecast period. The key factors that drive the elastomer infusion pump market growth are rise in demand for continuous rate elastomeric pumps, wide usage of continuous rate pumps in chronic disease treatment, the increase in the adoption of elastomer infusion pump for post-operative pain management, and an increase in application in cancer treatment are majorly driving the growth of this segment.
By application, the global elastomer infusion pump market is segmented into pain management, infection management, chemotherapy, and others. Pain management is the major shareholder in the global elastomer infusion pump market owing to the rise in the number of orthopedic procedures & surgeries, increase in use of elastomer infusion pumps for administration of analgesic drugs, and less complications are observed as compared to opioids dosage are the key drivers of the pain management segment.
Key Findings of the Study
Depending on product, the continuous rate pumps segment held 57.22% share in the global market in 2018.
On the basis of application, the pain management segment held the largest elastomer infusion pump market share in 2018 and is expected to remain dominant throughout the forecast period.
According to end user, the home care segment exhibits fastest growth and is expected to grow at a CAGR of 5.3% from 2019 to 2026.
Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 5.9% during the forecast period.
In 2018, North America accounted for the major share in the elastomer infusion pump market, and is expected to continue this trend during the forecast period, owing to availability of well-developed infrastructure, higher number of R&D activities with large presence of key players, rise in demand for elastomers infusion pumps, surge in prevalence of chronic diseases, and an increase in non-government & government initiatives to promote healthcare. However, Asia-Pacific is expected to register the highest growth in the future owing to improvement in healthcare infrastructure, and technological advancements in the field of healthcare, and the developing R&D sector.
Companies Mentioned
- B Braun Melsungen Ag
- Baxter International Inc.
- Halyard Health
- Heka Healthcare
- Nipro Medical Corporation (Nipro Medical Europe NV)
- Palex Medical SA
- Pfizer Inc. (Hospira Inc.)
- Pfm Medical Ag
- PROMECON GmbH.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
